NTRA Q4 2023 Earnings — Natera, Inc. Revenue & Financial Results | Market Cap Arena

NTRANatera, Inc.

$29B

Q4 2023 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$311M+43.2% YoY

Gross Profit

$160M51.4% margin

Operating Income

-$85M-27.2% margin

Net Income

-$78M-25.1% margin

EPS (Diluted)

$-0.65

QoQ Revenue Growth

+16.0%

Cash Flow

Operating Cash Flow

-$58M

Free Cash Flow

-$68M

Stock-Based Comp.

$49M

Balance Sheet

Total Assets

$1.4B

Total Liabilities

$676M

Stockholders' Equity

$765M

Cash & Equivalents

$642M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$311M	$217M	+43.2%
Gross Profit	$160M	$90M	+77.7%
Operating Income	-$85M	-$142M	+40.4%
Net Income	-$78M	-$143M	+45.3%

Revenue Segments

Product

$572M99%

Licensing and other

$7M1%

Geographic Segments

United States

$301M97%

Europe, Middle East, India, Africa

$7M2%

Asia Pacific and Other

$2M1%

Americas, excluding U.S.

$1M0%